May 15, 2012

---

SemBioSys announces first quarter results and provides update on activities

April 30, 2012

---

SemBioSys provides update regarding voluntary delisting from Toronto Stock Exchange and the current state of the company

April 4, 2012

---

SemBioSys announces voluntary delisting from Toronto Stock Exchange and pursuit of strategic alternatives

August 16, 2011

---

SemBioSys Genetics awarded key U.S. patent for the production of insulin in plants

September 1, 2010

---

SemBioSys Genetics granted key U.S. patent for the production of apolipoprotein in plants

January 18, 2010

---

SemBioSys provides update on GLA-rich safflower oil

January 13, 2010

---

SemBioSys announces senior management change

December 18, 2009

---

SemBioSys announces completion of $3.7 million non-dilutive capital transaction

December 10, 2009

---

SemBioSys receives $400,000 milestone payment from AVAC

October 30, 2009

---

SemBioSys enters in non-dilutive financing plan of arrangement

October 22, 2009

---

SemBioSys enters into commercialization and supply agreement for plant-made chymosin protein

July 30, 2009

---

SemBioSys awarded key U.S. patent for the production of insulin in plants

July 20, 2009

---

SemBioSys announces non-binding letter of intent with Avrio Ventures Limited Partnership and Botaneco